Advertisement

Ophthalmology

EyeTechCare, based in Rillieux-la-Pape, France, has received $13 million in funding from private investor Bernard Chauvin, insurer SHAM and Omnes Capital.

Andrew Holzman, MD, board certified ophthalmologist, has had his McLean, Va., practice site sanctioned by the FDA as a test site for the cross-linking treatment of kerataconus.

Advertisement

Mobius Therapeutics, ophthalmic surgery solutions company based in St. Louis, has announced that the Center for Medicare & Medicaid Services has given the company Outpatient Prospective Payment System Payment Indicator K2 for the reimbursement of Mitosol.

MacuLogix, a company focused on the detection and following of age-related macular degeneration, has announced that the company has received $3.6 million in Series A funding for its AdaptDx.

Advertisement